Sign in
CMVLF Stock Price, Chart, Stats & News
Cellectis S.A.
Save
Cellectis S.A. (CMVLF) does not currently pay a dividend.
251.93M
Market cap
–
Current P/E
–
Forward P/E
CMVLF chart
About
Health care
Sector
Biotechnology
Industry
Cellectis S. A. is a clinical-stage biotechnology firm dedicated to advancing immuno-oncology therapies. Their core technology involves engineering T-cells with gene editing to express chimeric antigen receptors (CARs), enabling these modified cells to precisely target and destroy cancer cells.
Similar securities
Based on sector and market capitalization
Report issue